72
Views
1
CrossRef citations to date
0
Altmetric
Research

Process evaluation of an intervention to improve access to injectable contraceptive services through patent medicine vendors in Nigeria: a mixed methods study

ORCID Icon, , , , , & show all
Article: 88 | Received 05 Mar 2021, Accepted 07 Jun 2021, Published online: 28 Nov 2023

References

  • United Nations. Trends in Contraceptive Use Worldwide 2015. Department of Economic and Social Affairs, Population Division; 2015. p. 1–70.
  • World Health Organisation. Trends in maternal mortality: 1990 to 2015: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. Geneva:World Health Organisation;2015. p.1–92.
  • National Population Commission (NPC) [Nigeria] and ICF International. 2014. Nigeria Demographic and Health Survey 2013. Abuja, Nigeria, and Rockville, Maryland, USA: NPC and ICF International.
  • National Population Commission (NPC) [Nigeria] and ICF. 2019. Nigeria Demographic and Health Survey 2018. Abuja, Nigeria, and Rockville, Maryland, USA: NPC and ICF.
  • OlaOlorun FM, Hindin MJ. Having a say matters: influence of decision-making power on contraceptive use among Nigerian women ages 35–49 years. PLoS ONE. 2014;9(6):e98702.https://doi.org/10.1371/journal.pone.0098702.
  • Blackstone SR, Iwelunmor J. Determinants of contraceptive use among Nigerian couples: evidence from the 2013 Demographic and Health Survey. Contracept Reprod Med. 2017;2(1):9.
  • Orji EO, Ojofeitimi EO, Olanrewaju BA. The role of men in family planning decision-making in rural and urban Nigeria. Eur J Contracept Reprod Heal Care Off J Eur Soc Contracept. 2007;12:70–75.
  • Campbell M, Sahin-Hodoglugil NN, Potts M.Barriers to fertility regulation: a review of the literature. Stud Fam Plann. 2006;37:87–98.
  • Sieverding M, Schatzkin E, Shen J, Liu J. Bias in contraceptive provision to young women among private health care providers in South West Nigeria. Int Perspect Sex Reprod Health. 2018;44(1):19–29.
  • Schwandt HM, Speizer IS, Corroon M. Contraceptive service provider-imposed restrictions to contraceptive access in urban Nigeria. BMC Health Serv Res. 2017;17(1):268.
  • Ajayi OO, Ajuwon AJ. Contraceptive knowledge and compliance with guidelines for providing contraceptive services by patent medicine vendors in Ibadan north local government area, Nigeria. Afr J Biomed Res. 2015;18:123–133.
  • Ajuwon AJ, Oshiname FO, Imaledo J, Ajayi OI, Dipeolu IO. Delivery and utilisation of injectable contraceptives services in rural Nigeria: learning from the perspectives of patent medicine vendors and women of reproductive age. Afr J Biomed Res. 2016;19(2):79–87.
  • Pharmacy Council of Nigeria guidelines for the issuance of the patent and proprietary medicines vendor’s license. Pharmacists Council of Nigeria. 2nd ed; 2009.
  • Federal Ministry of Health (FMOH). (2010) Federal Ministry of Health: Essential Medicine List, 5th Revision, Abuja, Nigeria
  • Dwyer SC, Ishaku SM, Okunade F, Reichenbach L, Jain A. Feasibility of patent and proprietary medicine vendor provision of injectable contraceptives: preliminary results from implementation science research in Oyo and Nasarawa, Nigeria. Contraception. 2018;98(5):460–462.
  • Stanback J, Mbonye AK, Bekiita M. Contraceptive injections by community health workers in Uganda: a nonrandomized community trial. Bull World Health Organ. 2007;85:768–773.
  • Stanback J, Lebetkin E, Orr T, Malarcher S. Sale and provision of injectable contraceptives in drug shops in developing countries: conclusions from a technical consultation. Contraception. 2015;91(2):93–96.
  • Corroon M, Kebede E, Spektor G, Speizera L. Key role of drug shops and pharmacies for family. Global Health: Sci Practice. 2016;4(4):594–609.
  • Oye-Adeniran B, Adewole I, Umoh A, Oladokun A, Gbadegesin A, Odeyemi K, et al. Sources of contraceptive commodities for users in Nigeria. PLoS Med. 2005;2(11):306.
  • Salisu I, Afolabi K, Dwyer S, Okunade F, Uzomba C, Adebayo A, et al. Examining and strengthening the role of proprietary patent medicine vendors in provision of injectable contraception in Nigeria. Research Report. Population Council, Washington, The Evidence project. 2018.
  • Lewis CC, Klasnja P, Powell B, Tuzzio L, Jones S, Walsh-Bailey C, Weiner B.From classification to causality: advancing understanding of mechanisms of change in implementation science. Front Public Health. 2018;6:136.
  • Kazdin AE. Evidence-based treatment and practice: new opportunities to bridge clinical research and practice, enhance the knowledge base, and improve patient care. Am Psychol. 2008;63(3):146.
  • Dwyer SC, Jain A, Ishaku SM, Okunade FT, Uzomba C, Adebayo A, Tobey E. The effect of job aids on knowledge retention among Patent and Proprietary Medicine Vendors trained to administer injectable contraceptives: longitudinal results from implementation science in Nigeria. BMC Public Health. 2019;19(1):1362.
  • Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. 2008;337:a1655.
  • Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, Moore L, O’Cathain A, Tinati T, Wight D, Baird J. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015;350.
  • Weiss C. Nothing as practical as good theory: exploring theory-based evaluation for comprehensive community initiatives for children and families.In: Connell JP, New approaches to evaluating community initiatives: concepts, methods, and contexts. Washington:Aspen Institute; 1995. p.65–92.
  • Maini R, Mounier-Jack S, Borghi J. How to and how not to develop a theory of change to evaluate a complex intervention: reflections on an experience in the Democratic Republic of Congo. BMJ Glob Health. 2018;3(1):e000617.
  • De Silva M, Lee L, Ryan G. Using theory of change in the development, implementation, and evaluation of complex health interventions. London: The Centre for Global Mental Health at the London School of Hygiene & Tropical Medicine and The Mental Health Innovation Network. 2014.
  • Fetters MD, Curry LA, Creswell JW. Achieving integration in mixed methods designs—principles and practices. Health Services Res. 2013;48(6pt2):2134–2156.
  • Riley C, Garfinkel D, Thanel K, Esch K, Workalemahu E, Anyanti J, Mpanya G, Binanga A, Pope J, Longfield K, Bertrand J. Getting to FP2020: harnessing the private sector to increase modern contraceptive access and choice in Ethiopia, Nigeria, and DRC. PLoS ONE. 2018;13(2):e0192522.
  • Leisher SH, Sprockett A, Longfield K, Montagu D, editors. Quality measurement in family planning: past, present, future: papers from the Bellagio meeting on family planning quality, 2015. Oakland: Metrics for Management; 2016.
  • Iheoma C.Impact of patent and proprietary medicine vendors training on the delivery of malaria, diarrhoea, and family planning services in Nigeria. Open Access Library J. 2016;3(08):1.
  • Daini BO, Anibi AU, Akin-Kolapo B, Fajemisin OA. Joint effect/interaction of detailing and trainings on coverage of family planning products among selected PPMV shops in Nigeria. Int J Public Health Res. 2018;6(2):26.
  • Tumlinson K, Hubacher D, Wesson J, Lasway C. Measuring the usefulness of family planning job-aids following distribution at training Workshops. J Bio Soc Sci. 2010;42(5):695–698.
  • Braun R, Lasway C, Agarwal S, L’Engle K, Layer E, Silas L, Mwakibete A, Kudrati M. An evaluation of a family planning mobile job aid for community health workers in Tanzania. Contraception. 2016;94(1):27–33.
  • Oshiname FO, Brieger W. Primary care training for Patent Medicine Vendors in rural Nigeria. Soc Sci Med. 1992;35(12):1477–1484.https://doi.org/10.1016/0277-9536(92)90050-Z.
  • Brieger W. Observations of interactions between patent medicine vendors and customers in urban and rural Nigeria. Health Policy Plan. 2004;19:177–182.
  • Brugha R, Zwi A. Improving the quality of private sector delivering of public health services: challenges and strategies. Health Policy Plan. 2002;13:103–120.
  • Jacobs C, Michelo C, Moshabela M. Implementation of a community-based intervention in the most rural and remote districts of Zambia: a process evaluation of safe motherhood action groups. Implement Sci. 2018;13(1):74.
  • Penn-kekana L, Powell-Jackson T, Haemnerli M, Mahapatra A, Sharma G, Singh K, Singh S. Shukla V and Goodman C (2018): Process Evaluation of Social Franchising model to Improve Maternal Health: evidence from a multi-methods study in Uttar Pradesh, India. Implement Sci. 2018;13:124.https://doi.org/10.1186/s13012-018-0813-y
  • Hebert LE, Schwandt HM, Boulay M, Skinner J. Family planning providers’ perspectives on family planning service delivery in Ibadan and Kaduna, Nigeria: a qualitative study. J Family Planning Reprod Health Care. 2013;39:29–35. http://www.familyplanning2020.org/news/training-community-pharmacists-improve-access-family-planning-services.
  • Beyeler N, Liu J, Sieverding M. A systematic review of the role of proprietary and patent medicine vendors in healthcare provision in Nigeria. PLoS ONE. 2015;10(1):e0117165.
  • Hort K, Gilbert K, Basnayaka P, Annear PL. Strategies to strengthen referral from primary care to secondary care in low- and middle-income countries. New Delhi: World Health Organisation Regional Office for South-East Asia; 2019.
  • Thomas JC, Reynolds HW, Alterescu X, Bevc C, Tsegaye A. Improving referrals and integrating family planning and HIV services through organisational network strengthening. Health Policy Plan. 2016;31(3):302–308.
  • Liu J, Prach L, Teleaven E, Hansen M, Anyanti J, Jagha T, et al. The role of drug vendors in improving basic health-care services in Nigeria. Bull World Health Organ. 2016;94:267–275.